Mediators of youth anxiety outcomes 3 to 12 years after treatment

Makover, Heather; Kendall, Philip C.; Olino, Thomas M.; Carper, Matthew M.; Albano, Anne Marie; Piacentini, John; Peris, Tara S.; Langley, Audra K.; González, Araceli; Ginsburg, Golda S.; Compton, Scott N.; Birmaher, Boris; Sakolsky, Dara; Keeton, Courtney; Walkup, John T.

doi:10.1016/j.janxdis.2020.102188

Cited by 5 publications

(4 citation statements)

References 129 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Indeed, proximal targets addressed by both the BA and GM SSIs, such as hope, 17 relate to depression and anxiety alike. Likewise, interventions designed to increase perceived agency 25 and active problem-solving 26 have reduced both anxiety and depression in youth. Thus, SSIs targeting agency and hope, like the BA-SSI and GM-SSI, may help reduce both depression symptom severity and anxiety and trauma symptoms linked to COVID-19.…”

Section: Nationwide Randomized Controlled Trial Of Single-session Interventions For Adolescent Depression In the Context Of Covid-19mentioning

confidence: 99%

A Randomized Trial of Online Single Session Interventions for Adolescent Depression during COVID-19

Jl¹,

Mc²,

Fox³

et al. 2021

Preprint

View full text Add to dashboard Cite

The COVID-19 pandemic caused financial hardship, social isolation, and distress, increasing risk for adolescent depression. Even before the pandemic, <50% of youth with depression accessed care, and not all benefited from existing treatments. Accordingly, this randomized-controlled trial tested online single-session interventions (SSIs) during COVID-19 in adolescents with elevated depression (N=2,452, ages 13-16). Adolescents recruited via social media were randomized to 1 of 3 SSIs: a behavioral activation SSI, an SSI teaching that personal traits are malleable, or a supportive control. We tested each SSI’s effects on post-intervention (hopelessness, agency) and 3-month outcomes (depression, hopelessness, agency, generalized anxiety, COVID-related trauma). Compared to the control, both active SSIs reduced 3-month depressive symptoms; decreased post-intervention and 3-month hopelessness; and increased post-intervention agency. Several differences between active SSIs emerged. Results confirm the effectiveness of two free-of-charge, online SSIs for adolescents with elevated depression, even in the high-stress context of COVID-19.

show abstract

Section: Nationwide Randomized Controlled Trial Of Single-session Interventions For Adolescent Depression In the Context Of Covid-19mentioning

confidence: 99%

A Randomized Trial of Online Single Session Interventions for Adolescent Depression during COVID-19

Jl¹,

Mc²,

Fox³

et al. 2021

Preprint

View full text Add to dashboard Cite

show abstract

“…Indeed, proximal targets addressed by both the BA and GM SSIs, such as hope 20 , relate to depression and anxiety alike. Likewise, interventions designed to increase perceived agency 22 and active problem-solving 26 have reduced both anxiety and depression in youth. SSIs targeting agency and hope (such as the BA-SSI and GM-SSI) may thus help reduce depression symptom severity, anxiety symptoms and trauma symptoms linked to COVID-19and potentially other forms of psychopathology not directedly targeted by the SSIs (for example, restrictive eating).…”

mentioning

confidence: 99%

A randomized trial of online single-session interventions for adolescent depression during COVID-19

et al. 2021

View full text Add to dashboard Cite

The COVID-19 pandemic has potentially increased the risk for adolescent depression. Even pre-pandemic, <50% of youth with depression accessed care, highlighting needs for accessible interventions. Accordingly, this randomized controlled trial (ClinicalTrials.gov: NCT04634903) tested online single-session interventions (SSIs) during COVID-19 in adolescents with elevated depression symptoms (N = 2,452, ages 13-16). Adolescents from all 50 US states, recruited via social media, were randomized to one of three SSIs: a behavioural activation SSI, an SSI teaching that traits are malleable and a supportive control. We tested each SSI's effects on post-intervention outcomes (hopelessness and agency) and three-month outcomes (depression, hopelessness, agency, generalized anxiety, COVID-19-related trauma and restrictive eating). Compared with the control, both active SSIs reduced three-month depressive symptoms (Cohen's d = 0.18), decreased post-intervention and three-month hopelessness (d = 0.16-0.28), increased post-intervention agency (d = 0.15-0.31) and reduced three-month restrictive eating (d = 0.12-17). Several differences between active SSIs emerged. These results confirm the utility of free-of-charge, online SSIs for high-symptom adolescents, even in the high-stress COVID-19 context.

show abstract

“…Studies have reported a range of effects with SSRI treatment either alone or in combination with CBT which are associated with clinical response, although most studies use self-report measures making it difficult to understand the underlying mechanisms of change. These include improved emotional reappraisal, 92 enhanced problem solving ability, 93 decreased perfectionism, 94 decreased hopelessness, 95 improved coping efficacy, 96 decreased negative interpretative bias, 97 reduced somatic symptoms, 98 reduced social distress and behavioural avoidance 99 and improved sleep. 100,101…”

Section: Corticolimbic Circuitry and Affective Processingmentioning

confidence: 99%

The knowns and unknowns of SSRI treatment in young people with depression and anxiety: efficacy, predictors, and mechanisms of action

Murphy

Capitão

Giles

et al. 2021

The Lancet Psychiatry

View full text Add to dashboard Cite

Mediators of youth anxiety outcomes 3 to 12 years after treatment

Cited by 5 publications

References 129 publications

A Randomized Trial of Online Single Session Interventions for Adolescent Depression during COVID-19

A Randomized Trial of Online Single Session Interventions for Adolescent Depression during COVID-19

A randomized trial of online single-session interventions for adolescent depression during COVID-19

The knowns and unknowns of SSRI treatment in young people with depression and anxiety: efficacy, predictors, and mechanisms of action

Contact Info

Product

Resources

About